A--NIMHD Randomized Controlled Trial
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NICHD
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N94027R00004
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AN12
Additional Details
Documents1
The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), has issued a presolicitation notice for a forthcoming procurement titled "NIMHD Randomized Controlled Trial." This initiative seeks to conduct a randomized controlled trial (RCT) evaluating a novel clinical decision support tool designed to provide individualized exercise recommendations for breast cancer survivors. The primary aim of this procurement is to advance research in personalized exercise interventions, potentially improving health outcomes and quality of life for this patient population.
The scope of work encompasses the design, implementation, and rigorous assessment of the clinical decision support tool within a randomized trial framework. Contractors will be expected to demonstrate expertise in research and development within the physical, engineering, and life sciences, as indicated by the NAICS code 541715. The trial will focus on the practical application of the tool, measuring its effectiveness in tailoring exercise regimens to the unique needs of breast cancer survivors. Key deliverables will likely include the development and deployment of the support tool, comprehensive data collection and analysis, and detailed reporting of trial outcomes.
The procurement is classified under Product Service Code AN12, which pertains to research and development in health-related areas. The contracting entity is the NIH NICHD, operating under the Department of Health and Human Services. The primary point of contact for this opportunity is Gannon P. White, who can be reached via email at [email protected] or by phone at +1 301 402 9178.
This presolicitation notice is active, with a posting date of October 11, 2026, and a response deadline of November 25, 2026. Interested parties should refer to the official notice on SAM.gov (Opportunity ID: 747060a589d84c36b2e9a73a141a9651) for further details and any available attachments. The procurement is federal in nature, and no specific set-aside requirements or special considerations have been indicated in the notice.
Contractors considering this opportunity should possess robust capabilities in clinical research, trial management, and the development of decision support technologies. The project is expected to maintain its focus on individualized exercise recommendations for breast cancer survivors throughout its lifecycle, with an emphasis on scientific rigor and translational impact.